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Abstract: Aging refers to progressive physiological changes in a cell, an organ, or the whole body of an
individual, over time. Aging-related diseases are highly prevalent and could impact an individual’s
physical health. Recently, artificial intelligence (AI) methods have been used to predict aging-related
diseases and issues, aiding clinical providers in decision-making based on patient’s medical records.
Deep learning (DL), as one of the most recent generations of AI technologies, has embraced rapid
progress in the early prediction and classification of aging-related issues. In this paper, a scoping
review of publications using DL approaches to predict common aging-related diseases (such as
age-related macular degeneration, cardiovascular and respiratory diseases, arthritis, Alzheimer’s and
lifestyle patterns related to disease progression), is performed. Google Scholar, IEEE and PubMed
are used to search DL papers on common aging-related issues published between January 2017 and
August 2021. These papers are reviewed, evaluated, and the findings are summarized. Overall,
34 studies met the inclusion criteria. These studies indicate that DL could help clinicians in diagnosing
disease at its early stages by mapping diagnostic predictions into observable clinical presentations;
and achieving high predictive performance (e.g., more than 90% accurate predictions of diseases
in aging).
Keywords: aging; deep learning; classification; prediction; PRISMA
1. Introduction
Aging refers to the persistent decline in the age-specific fitness due to internal physio-
logical changes, anatomical, and immunological changes in living beings [1]. Physiological
changes are usually associated with a wide range of disorders, including neurodegenera-
tive, cardiovascular, respiratory, and eye-related diseases [2]. Efforts to early detection of
diseases in aging population and related therapeutics have now become a hot topic of re-
search. Cutting edge modern computing technologies in Artificial Intelligence (AI) such as
Deep Learning (DL) are being recently applied to improve understanding of aging-related
diseased conditions and have been engaged to assist clinicians and healthcare profession-
als for improved decision-making [3]. DL-based algorithms indicate great potential in
extracting features and learning patterns from complex and heterogeneous medical data
pertaining to an individual’s health status. Such data may involve medical images, such as
scans from imaging devices; genomic data relating human genes to diseases; smart sensor
data to detect medical conditions and their effects; data from electronic health records
(EHRs); and the time series data from electrograms [4]. DL methods aid in learning these
data representations to predict diseased states related to aging [4]. DL transforms the
data through layers of nonlinear computational processing units, providing knowledge
discovery from the complex data. In recent years, DL algorithms have indicated superior
performance in many data-rich application scenarios relating to the healthcare of the aging
population.
In previous review studies, Taeho Jo et al. [5] reviewed DL approaches and neuroimag-
ing data for the early detection and diagnostic classification of Alzheimer’s disease (AD),
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one of the most common diseases in the aging population. Shoukry et al. [6] conducted a
mini-review highlighting the use of DL in AD detection. Yue et al. [7] provided a concise re-
view of DL applications in various aspects of genomic research, indicating disease-causing
genes. Li et al. [2] conducted a review on aging and age-related diseases. Kieu et al. [8] pro-
vided a survey of DL for detecting lung diseases. Wang et al. [9] highlighted the adoption of
DL in systems medicine with a special emphasis on predictive modelling for personalized
Parkinson’s disease. In their review, Wang and Chen et al. [10] did a survey on using DL in
sensor-based activity recognition. To best of our knowledge, a review highlighting using
DL in predicting a variety of healthcare issues in aging is missing in the literature.
To extend upon this, we aim to provide a scoping review of the existing research,
applying DL methodologies on the analysis of different types of aging-related diseases
utilizing different kinds of data to predict diseased conditions. A scoping review is one of
the newer review types used to emphasize conceptual boundaries of a topic or field [11].
The boundaries of the current scoping review enclose the applicability of DL models to
effectively predict aging diseases and issues in the past few years (2017–2021). This review
would help to understand the use of DL in surrogate of age-related health versus diseases
with multiple phenotypes, such as biological targets, cardiovascular aging, eye pathology,
lifestyle patterns, immune decline, lung function, bone and knee joints aging.
In the current review, we first briefly provide a background of state-of-the-art DL
techniques. Then, we perform the scoping review of the literature relevant to DL applica-
tions in detecting aging-related diseases. According to the most common aging problems,
we categorized the relevant articles from the scoping review into six co-groups. Differ-
ent types of data were analysed under different diseased states including the following
aging-related diseases: age-related macular degeneration, cardiovascular and respiratory
diseases, Alzheimer’s, arthritis, lifestyle, and other patterns in disease progression in ag-
ing people. We also discuss principal findings and challenges in using DL algorithms to
improve diagnostic classification in aging diseases and suggest some promising future
directions.
1.1. Conceptual Modelling with DL to Solve Aging-Related Diseases
Aging is a universal mechanism, driven by changes at different stages of life in human
beings. In this paper, we review how data from large human medical studies and analytical
approaches borrowed from DL can help to fight against aging-related diseases. With such
an approach, we hope to generate predictive models for detecting novel therapeutic targets
for future aging interventions. The association of most physiologically relevant variables
with age is a hallmark of aging studies in humans. Chronic age-associated diseases may
share genetic, biological, and psychological traits over a time period. Strategies for human
life extension involve targeting resilience with interventions that increase human life, and
developing therapies aimed at a reduction in the number of aging-related diseases. DL
systems trained on measurable health related variables (changing over time) could help in
learning various such biological processes. Combining the prevention and early detection
of aging diseases by adding a computational approach of DL would yield better outcomes
in that it would promote better treatment and care procedures. Control of the aging
process is driven by data acquisition from patients and the control group. Investigations of
aging dynamics is supported by experiments with medical images, time series data, and
genomic markers, etc. obtained from aging patients and control subjects. DL approaches
help perform such investigations and facilitate new clinical trials to minimize functional
declines associated with aging. The most common physical health conditions associated
with aging are respiratory diseases, cardiovascular diseases, Alzheimer’s disease, arthritis
and age-related macular degeneration [12]. We envision the review of joint use of DL over
big data obtained from medical images, electronic medical records, research databases,
personalized genomics and wearable sensor data for continuous monitoring of aging
patients’ health and risks of aforementioned diseases. DL has been successfully applied
to imaging data to determine features that are associated with the detection of clinical
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diseases and also to more accurately classify disease progression in tissue-based studies [13].
DL has also been utilized over blood biochemistry parameters and cell count linked to
chronological age with other factors such as sex and lifestyle [14]. In [15], DL methods
identified albumin, glucose, alkaline phosphatase, urea and erythrocytes as biomarkers for
determining the chronological age of human beings [14]. The attractive feature of DL is to
identify relevant patterns within complex and nonlinear medical data. A conceptualized
framework embedding DL within the complex context of aging-related diseases is shown
in Figure 1.
Figure 1. A generalized conceptual framework for applying DL to aging-related diseases.
The proposed review aims to showcase the potential of DL-based computational
models in clinical and healthcare frameworks for age-related diseases. It focuses on the
latest advances in DL approaches to process multi-data sources, such as neuroimages,
electrophysiological time-series, multi-modal biomedical data, electronic health records,
etc. for deployment in a range of clinical and healthcare solutions developed for aging
people, shown in Figure 1.
Remarkably, DL models have achieved clinician-level accuracy at different diagnostic
tasks, such as retinopathy and referrals from fundus images [15], optical coherence tomog-
raphy (OCT) images of the eye [16], and brain analysis with magnetic resonance imaging
(MRI) [17].
DL has even been shown to be effective in different medical image modalities (e.g.,
computed tomography (CT), MRI, ultrasound imaging and planar X-ray, ingle-photon
emission computed tomography (SPECT), positron emission tomography (PET) and hybrid
imaging systems, such as PET/CT, etc.) [18]. However, real-world clinical settings involve
external factors, such as the patient history, health records, any additional tests, such as
blood tests, patient testimony, lifestyle patterns, etc., with medical imaging analysis. DL
methods also aim to model temporal sequence (time-based sequences) of structured events
that were recorded in a patient’s electronic health records with convolutional and recurrent
neural networks in order to predict future medical incidents, such as mortality, patients’
stay for medical care and other diagnosis predictions [19,20].
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DL has also been adapted to work with genomic data (gene representations) to in-
fer DNA sequences, the effects of DNA mutations on gene splicing, and the effects of
genetic mutations on disease risk or drug response. Understanding such genetics of dis-
ease allows health care professionals to recommend better treatments and provide more
accurate diagnoses [21]. Recently DL has been successfully used to perform the classifica-
tion of cellular senescence (a state in which human body cells can no longer divide and
become a therapeutic target; a hallmark of aging) for finding drugs that control cellular
senescence [22].
1.2. Background on DL Models
DL [23] has emerged as the most important pillar in ML models. It is based on artificial
neural networks [24] and is gaining popularity because of its rich applications in the areas
of image processing, time series recognition, natural language processing, computational
biology, drug designing, and many more. DL is a technique for classifying information
through layered neural networks, an imitation of how the human brain works [25]. Artifi-
cial neural networks have a set of input units, where raw data are fed. This input can be
pictures, sound samples, or written text. The inputs are then mapped to the output nodes,
which determine the category to which the input information belongs [25]. Processing in
multiple layers in DL refers to a procedure in which the current layer takes the output of
the previous layer as an input. The success of DL methods is attributed to their ability
to perform feature engineering or transformation layer by layer [26]. Each layer has a
functional unit doing the transformation of the data received from the previous layer and
then passing the results to the next layer as depicted in Equation (1).
mk.l = f (x1, l−1, · · · , xn, l−1) (1)
where n is the number of computational units (neurons) in the (l − 1)th layer; mk.l represents
the output from the kth unit in the lth layer, and xi, l represents the input from the ith unit in
the (l − 1)th layer. Several hidden layers between the input and output nodes, make DL
methods capable of making much more complicated classifications of data. Each neuron
(also known as a node/cell/unit) is fully connected to nodes in the previous layer by
modelling in such a way that the strength of each connection to the previous layer is
represented by weight and an activation function, which is applied on the weighted sum
to derive output for the next layer, shown in Figure 2.
Figure 2. Illustration of an artificial neural network.
With the algorithmic development of DL methods, various hardware architectures
have emerged in previous years [27]. The trends in DL methods that were recently pub-
lished are listed in Table 1.
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Table 1. Various kinds of DL methods.
ANN [28] Artificial Neural Network
CNN [29] Convolutional neural network
DNN [30] Deep neural network
RNN [31] Recurrent neural network
RBM [32] Restricted Boltzmann machine
GAN [33] Generative adversarial networks
DBM [34] Deep Boltzmann machine
DBN [31] Deep Belief Network
AE [31] Auto Encoder
SAE [5] Stacked auto-encoder
HMM [35] Hidden Markov Model
The most famous types of DL methods are discussed in this section; these include
DNN, CNN, AE, and RNN [31].
• DNN
ANNs, shown in Figure 3, having more than one hidden layer in their architecture,
are known as DNNs, which have the capability to process complex data with the help of
mathematical modelling [31]. ‘Deep’ in DNN implies the number of processing layers
through which the raw data are transformed. DNNs are also known as Feed Forward
Neural Networks (FFNNs) as the flow of information is unidirectional in the forward
direction. DNNs are DL models composed of multiple nodes (neurons) in a hierarchical
organization, inspired by biological neurons of the human brain [28]. The nodes are
interconnected with weights on the links to interact with each other in different layers. The
nodes have the capability of processing input data and performing simple computational
operations on the input data. The result of these operations is passed to other neurons. The
propagation function determines the input to the next level neuron from the outputs of
its predecessor neurons and their interconnections as a weighted sum. The output at each
node is known as the activation (node) value. DNNs are capable of learning, which takes
place by altering the weight values [36]. The data are passed from the input layer to the
next level layer, until they reach the output layer, where they provide the prediction of
yes or no based on probability. The weights are optimized to make sure that the network
makes a correct prediction.
Figure 3. An illustration of a simple DNN with two hidden layers.
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• CNN
The first used CNN was in 1989 for handwritten zip code recognition by LeCun
et al. [37]. A typical CNN architecture consists of different convolutional and pooling layers,
stacked alternatively [38]. Convolution operation is used to extract features maintaining
the spatial arrangement of pixels in input data (primarily images). It involves a linear
operation that involves combining an input data with a filter/feature selector (i.e., kernel)
generating a feature map depending on three dimensions: depth (number of kernels),
stride (the number of data units shifted over the input data) and padding (the number of
additional units added to the input), shown in Figure 4 [38].
Figure 4. Convolution operation.
The commonly used activation function of rectified linear units (ReLU) is a non-linear
operation and is applied to convolved feature maps [39]. Pooling on a rectified feature map
reduces the size of each map while preserving the most important features. It slides over the
feature map by using famous mathematical operations of max, average and sum functions.
Finally, the classification is performed based on the output from the convolutional and
pooling layers using a fully connected network. The linear activation function ‘Softmax’ is
applied to this last level to derive the final output [39]. CNNs have been primarily applied
to image processing, raising the need to carefully transform non-image data, to an image
form [5].
• AE
AE was introduced in 1986 by Rumelhart et al. [40]. AE is an unsupervised artificial
neural network that encodes (compresses) the input data and also learns to reconstruct
the original data back from the reduced encoded representation [27]. By using AEs, high-
dimensional data can be dimensionally reduced (by an encoder) and reconstructed back
by decoder without significant loss of information by learning how to reduce noise in
data. A variety of deep autoencoder architectures have been proposed in the literature [31]
showing great potential in healthcare.
• RNN
RNNs process sequential information (inputs) in DL models and retain its previous
state while processing the next sequence of inputs [31]. Its architecture is driven by cyclic
connection and recurrent units Figure 5. RNN’s hidden state remembers some details on
an input sequence. The state at each time t is estimated in RNNs based on the previous
hidden state and the current input as defined in Equation (2), allowing learning through a
recurrent sequential approach [41].
ht = f (WRNht−1 + WIN xt) (2)
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where WRN is weight at recurring neuron, WIN is weight at input neuron, ht−1 is the
previous state, ht is the current state and xt is the input state.
Figure 5. A simple illustration of RNN and ANN.
These are unlike traditional neural networks which assume each input to be inde-
pendent of the other Figure 5. A novel RNN approach was recently devised to model
dependencies in brain networks based on the mechanism of functional magnetic resonance
imaging (fMRI) [5].
• DBN
DBNs were introduced in 2007 by Larochelle et al. [42], as a probabilistic generative
model that can work better for studies involving traditional neural networks training in
deep layered networks, facing issues such as slow learning, poor parameter selection,
getting stuck in local minima and requiring many training datasets. Generative models pro-
vide joint probability distribution over input data and labels [32]. DBNs consist of several
layers of neural networks, also known as “Boltzmann Machines” [34]. In DBNs, train-
ing occurs layer-wise while adjusting the weight parameters and balancing the learning
probability [31,34].
Various DL frameworks are increasingly being used in various kinds of applications.
AlexNet was a turning point in the history of DL, providing excellent results in image
classification [43]. Other frameworks also subsequently emerged, such as VGGNet, Incep-
tion and ResNet for working with ImageNet data [43]. These would be beneficial in their
application to medical image data.
1.3. Data Types Pertaining to Age-Related Diseases
Determinants of age-related diseases may involve a variety of data obtained from
varied sources, shown in Figure 6. Variability, quality and complexity of data are the major
challenges in analysing such data [44]. Nonetheless, the integration of heterogeneous data
types and their use in DL modelling architecture is a potential direction of research [45]. DL
facilitates an analysis of the heterogeneous and unstructured data obtained from medical
images, medical-grade wearable devices and omics data, with mathematical functions
aimed at learning patterns in input data [45–47]. Imaging data could involve tomographic
imaging modalities, in particular on CT and MRI data, 3D visualizations of the relevant
anatomical structures, e.g., 3D ultrasound, positron emission tomography (PET), X-rays,
etc. [47].
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Figure 6. Potential data types in detecting aging-related diseases.
The revolution in omics approaches (e.g., genomics, metagenomics, and proteomics)
has led to a better understanding of human genes and their linkage to diseases. Omics data
are becoming more accessible and are capable of classifying genes, as they are associated
with phenotypes of multiple age-related [48]. In this context, DL has emerged as a powerful
methodology to process probability by which gene associations with age-related diseases
are occurring. DL methods provide a supportive layer-by-layer architecture to combine
(integrate) several sources of biological data. Human protein coding genes are available
from NCBI BioMart v. 87 [49] and age-related disease gene associations can be derived from
a subset of the Genetic Association Database [50]. An interesting dataset can be obtained
for linking genes with age-related issues from a study by Fabris et al. [48]. Human aging is
attributed to a combination of genomic to environmental factors, such as lifestyle patterns,
and is henceforth considered to be heterogeneous [2].
Wearable devices have emerged as one of the technological frontiers to associate
technology with people’s daily lifestyles for organizing their medication regimen and
improving life. Individuals can wear sensors to track various activities, such as cardiac
health, treatment effect, physical activity, sleep patterns, potential illness, and disease
characteristics [51]. The authors in [52] suggested technology design recommendations for
wearables intended for an older population. Wearable technologies help collect data from
people to be fed into computational models. Nonetheless, such technology-driven medical
and analytical platforms deal with large and complex data which may include high variance
and intrinsic collinearity. However, in humans, sometimes because of ethical issues, the
capacity of experimentations is limited and, therefore, research related to age-related issues
involve observational data, including self-reporting data [53].
One of the most popular applications of DL is to classify image lab test results, imaging
and other specialist investigation data obtained from medical care. Image data repositories
can be availed from [54]. Integrating electronic health records with OpenEHR, FHIR, and
EHCR is at the development stage to provide data management and access for analysis [55].
2. Methods
DL approaches have immense potential to improve diagnostics and clinical paths
to achieve better outcomes. DL-based approaches offer effective solutions towards data
complex medical imaging data processing and analysis, which is useful for the diagnosis of
age-related issues [47]. Current methods primarily deal with finding markers of diseases,
reporting and detecting human diseases, and monitoring elderly people [56]. For example,
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DL can involve the heterogenous data of elderly patients [57], use of wearable technol-
ogy [51] to monitor individual health status, such as cardiac rhythms and movements and
their daily lifestyle [58], biometric data [59], and human genes [48], etc., and can advance
the analysis of such unstructured data to relevant diagnostic information by removing
anomalies and deriving useful patterns.
DL has been used to detect and classify diseases such as lung cancer and pulmonary
nodules from CT imaging [60], neurodegenerative diseases [61], Alzheimer’s disease from
fMRI and MRI scans [6], eye-related disorders [15], and detection of skin diseases from
photographs [62]. These studies are dependent on large volumes of training data to achieve
better DL classification performance. DL approaches, such as CNNs and RNNs, mainly
use input data without explicit feature selection and have yielded good accuracies (e.g.,
96.0% for Alzheimer’s classification [5]).
DL is a nascent field and has evolved rapidly in the past few years to learn massive
amounts of data from cognitive tasks. This review attempts to provide a comprehensive
survey of enhancements recently added to the field of applying DL in predicting different
age-related diseases. In this paper, we intend to review DL-based models associated with
the diagnostic prediction of age-related disease issues. However, one of the key challenges
in these studies is the high degree of variability in aging-related changes in response to
the cognitive function in people. The predictive and preventive medicinal approach aims
to predict the probability of a patient developing a disease, thereby enabling either better
medical care by early diagnosis and the treatment of that disease. The use of DL methods
has been greatly explored in this approach to identify elderly subjects at high risk for
adverse conditions thereby prevention, screening and studying lifestyle interventions.
This review is guided by the preferred conceptual boundaries, as highlighted by Peters
et al. in their publication [11]. A Google Scholar, Institute of Electrical and Electronics
Engineers (IEEE Xplore), and PubMed search was carried out to identify DL papers on
detection of age-related diseases, published between January 2017 and August 2021. These
papers were reviewed, evaluated, and classified by different kinds of diseases and types
of data, and the findings were summarized. The summary of factors considered in this
review is noted in Table 2.
Table 2. The details of scoping review.
Scoping Review Title Role of DL in Predicting Age-Related Diseases:A Scoping Review
Review objective
To investigate the current state of DL methods in
detecting age-related diseases and provide better patient
care (such as early detection of age-related diseases).
Review question How DL can help in predicting age-related diseases tounderstand the fundamental mechanism?
Population Elderly human population is considered, excluding thechildren and youth.
Concept
The current review studies the trend in the last five
years (2017–2021) of using DL, to classify predictive
stages of common age-related diseases (such as AMD,
Arthritis, Cardiovascular and Respiratory diseases, etc.)
Context
Use of medical imaging data, genomic data, Electronic
Health Record data and data collected from wearable
sensors to predict the human diseases.
Types of evidence source
Analysis of heterogenous and unstructured data to
derive relevant diagnostic information aiding patients in
old age.
Participants Mostly participants with a mean age of 60–75 (nearly).
Although aging issues may occur due to people’s physical and social environments,
genetic variations, as well as due to their personal characteristics and lifestyles. These facts
may start to influence the process of aging and health at an early stage (40–50 years).
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We conducted a review of previous studies that used DL approaches for the diagnostic
classification of diseases in people with a mean age of nearly 60–75 years. The search
strategy is outlined using the Preferred Reporting Items for Systematic reviews and Meta-
Analyses (PRISMA) [63] flow diagram, shown in Figure 7, and is discussed below.
• Identification
To thoroughly review the literature, a two-step method was used to retrieve all the
studies on a relevant topic—(i) a keyword search was conducted to find relevant articles
from Google Scholar, PubMed and IEEE. The keywords used were “Deep Learning”, “old
age”, “aging”, “age-related disease”, “prediction”, “classification”; (ii) articles were sorted
by relevance.
The sample search queries were set to “Deep Learning”, “old age” or “aging” or
“age-related disease”, “prediction”, “disease”, “classification” for Google Scholar; [(Deep
Learning) AND ((age-related) OR (old age) OR (aging) AND (disease) AND (prediction)
OR (classification))] for PubMed search; and to [((“Full Text and Metadata”: Deep Learning)
AND ((“Full text and Metadata”: old age) OR (“Full text and Metadata ”: age-related)
OR (Full text and Metadata: aging) AND (“Full Text and Metadata”: prediction) OR-
related) AND (“Full Text and Metadata”: Classification) OR -related) AND (“Full Text and
Metadata”: disease))].
1804 articles were retrieved by the keyword search on Google Scholar, PubMed, and
IEEE. The keyword search was extended after removing “young”/“children” words to
avoid studies involving younger people (1648 articles were retained in the process). The
duplicate articles obtained from the three platforms were removed, leaving behind 842
articles. The articles were then sorted by relevance via recommendations available at the
search platforms listed above. The top 100 recommended articles were considered for the
review.
• Screening
We excluded survey or review papers, theses, book chapters and patents. To the best
of our knowledge, previous studies have conducted a scoping review of DL applications
in detecting a particular disease, such as Alzheimer’s [64], lung diseases [8] and mental
health issues [65]. However, our scoping review is focused on DL applicability in a variety
of common diseases associated with aging, not restricting any of them.
The remaining articles were screened based on the primary focus of the current
review. Abstracts were screened to understand the application of DL in aging-related
disease prediction. The articles intending to perform diagnostic classification, detection or
identifying factors leading to potential age-related diseases were included. Post-abstract,
full articles were screened. Articles considering the mean age of patients of 60–75 (nearly)
were included in the review. The articles proposing DL, without implementing it, were
removed. Preference was given to highly cited articles. In total, 66 papers were excluded
after screening.
• Eligibility
After the screening step, the remaining 34 papers were included in this review dealing
with different kinds of diagnostic classification of the common age-related diseases [66].
These were categorized with keywords into DL analysis related to common diseases of
“arthritis”, “age-related macular degeneration (AMD)”, “cardiovascular and respiratory
diseases”, “sensor-based lifestyle monitoring”, “Alzheimer’s disease (AD)” with some
other aging-related issues involving “type-2 diabetes”, “predicting brain age”, “narrowing
of blood arteries”, “COVID-19” effect on old-aged persons, “retinal fundus”, and linking
genes to aging diseases.
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Figure 7. PRISMA flow for the current Scoping Review.
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3. Results
A total of 34 papers were included in this review. Tables A1–A6 in Appendix A
provides the summary of diagnostic prediction of different age-related diseases with DL-
based classification methods adopted in the study. Included articles were examined to
retrieve the study of disease condition, application, material and methods with an age range
of the population, important findings within the set-up environment and performance of
the proposed model. The review deals with DL approaches that could be used to predict
varied aging-related diseases with joint use of features, such as images, demographics,
medical records, temporal data or genotypes as illustrated in Figure 8. The DL methods play
a role in decision support systems for clinicians by increasing the predictive performance.
Figure 8. Multimodal feature vectors input to DL methods applied for predicting aging-related diseases.
This systematic scoping review highlights studies involving various kind of aging-
related common issues considering varied input feature vectors (as shown in Figure 8).
• Age-related macular degeneration (AMD)
Age-related macular degeneration (AMD) is one of the leading causes of visual loss
in the aging population (60–90 years). Methods of DL are useful in better predicting
the severity of AMD using imaging methods. DL methods could be used for the public
screening or monitoring of AMD worldwide and could further assist in referring the aging
population, susceptible to AMD, to a health care provider.
In an interesting study by Qi Yan et al. [15] examined genotype and fundus images
of AMD patients which were used as inputs to DL models to dynamically predict an eye
that is progressing to the late AMD state, providing disease-severity-related phenotypes.
The study indicated that AMD is associated with age, smoking status and a number of
genetic variants. As late AMD is irreversible, such a prediction in the early stages would
aid patients to adopt preventative care, slowing disease progression. DL methods served
as efficient decision support systems (averaged area under the curve (AUC) value of 0.85
(95%CI: 0.83–0.86)), thereby providing various eye services by reducing assessment time
and finances via automated analysis. The authors provided a web-based application avail-
able online: http://www.pitt.edu/~qiy17/amdprediction.html (accessed on 17 October
2021) to predict AMD state, using both fundus images and genotypes. This could better
aid clinicians in predicting year-wise progression of AMD and providing preventive care
for patients. The study by Chuan and Yeung et al. [67] served as the first study to use
multimodal DL–based architecture for detecting multiple retinal vascular vision threaten-
ing eye diseases using multiple image modalities, including retinal fundus photography,
optical coherence tomography (OCT), and fluorescein angiography with or without in-
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docyanine green angiography (FA/ICGA). AUCs of 0.987 and 0.969 were attained for
predicting retinal vascular diseases and for predicting eye-treatment-requiring diseases.
Multimodal imaging is similar to real-world ophthalmology practice, helping in the early
screening of the eye diseases and treatment requirements, saving time and making it easy
for ophthalmologist on reviewing the images.
Peng et al. [68] proposed a DL-based model “DeepSeeNet”, which closely resembled
the decision support system of clinicians to identify the severity of patient-level AMD using
fundus images of both eyes. It is not purely a black-box approach and rather simulates
the human grading process by first detecting individual risk factors, such as pigmentary
abnormalities in each eye and then combining values from both eyes to develop a disease
score for the patient. DeepSeeNet performed patient-based AMD severity classification
with a higher level of accuracy than as predicted by a group of human retinal specialists.
Burlina et al. [69], proposed that DL-based models could help in better determining the
5-year risk of progression to advanced stages of AMD. DL approaches support automated
and more granular classification from fundus images, unlike traditional computational
models, depending on computing or human engineered features from eye-image clas-
sification. In the study, the authors created a 9-step scale supporting the more detailed
predictability of the potential development of advanced AMD in human beings. In this
process, DL-based methods refined retinal diagnostics by delineating fundus and OCT
images. The authors highlighted that the DL-based approach allows for better predictive
accuracy even in the absence of trained human experts. This could help in the identification
of patients at very high risk of progression to advanced AMD. Such patients could be given
better counselling for taking preventive treatments at the initial stages.
Banerjee et al. [16], proposed a hybrid sequential prediction model, called “Deep
Sequence”, integrating engineered imaging features and demographic factors to predict the
risk of developing non-exudative AMD eyes. Spectral-domain OCT (SD-OCT) represents a
gold standard in diagnostic imaging and the management of macular diseases. DL was
used in this study to determine indicators of possible disease progression from SD-OCT
scans collected at different timestamps (from 3 months to 21 months) along with the
demographic features. Imaging features extracted from SD-OCT describing the presence,
number, extent, density and relative reflectivity of drusen were used as predictors of AMD
progression.
With the advent of more advanced-feature extraction and classification, using DL
seems to be more supportive of the clinical assessment in early intervention studies to iden-
tify aging patients with high risk for progression to advanced AMD. Careful monitoring
and detecting preferred practice patterns, identifying individuals at the intermediate AMD
stage in a timely manner, can reduce the risk of vision loss due to AMD in aging persons.
DL aids in the fine categorization of clinically relevant features of AMD to guide patients
who need an ophthalmologist’s opinion. Table A1 in Appendix A summarizes interesting
studies relating DL to AMD.
• Cardiovascular and Respiratory Disorders in Aging People
The prevalence of cardiovascular and respiratory diseases also increases with age
and could be the cause of morbidity and mortality in older patients. Table A2 presents
a summary of studies relating to cardiovascular and respiratory diseases in the scope of
the current review. Heart disease is the first cause of death after age 65 [70]. Henceforth it
becomes important to deal with such issues with advanced methods.
In a study by Zhang et al. [70], DL techniques were applied to predict complications
of coronary heart disease in aging patients with an accuracy rate of 87.50%, which further
provided a guiding nursing plan. High-risk patients with coronary heart disease related to
old age, medical history and lifestyle patterns to predict complications for implementing a
better care plan.
The authors in [71] trained DL models on heart MRI videos, ECGs and heart health
indicators obtained from UK Biobank participants to identify biomarkers and clinical
phenotypes, associated with accelerated heart aging. Heart aging is a measure of the
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changes that have accumulated in the individual’s heart over their life span having two
main heart facets of heart anatomical (MRI-based) and electrical (ECG-based) aging. These
facets contain valuable signals and information which needs to be processed at a pace
surpassing “traditional” analytical methods. Using DL methods provided a platform to
integrate, analyse and make predictions based on the heterogeneous data of MRI scans,
ECG signals and environmental phenotypes of age, smoking and hereditary status. DL
was used in [72] to analyse chest radiographs for obstructive lung disease in aging people.
The results in [72] indicate that a DL Image Model, improves the detection of obstructive
lung disease compared to current practices. The results can be used to direct patients to
the medical care of pulmonary diseases and lung cancer screening augmenting radiology
clinical reports.
The authors in [73] further studied 10 common abnormalities on chest radiographs in
aging people, namely (pneumothorax, mediastinal widening, pneumoperitoneum, nod-
ule/mass, consolidation, pleural effusion, linear atelectasis, fibrosis, calcification and
cardiomegaly) using DL models to establish their diagnostic accuracy and timeliness of
reporting. The proposed approaches rearranged chest radiographs improving radiologists’
performance, shortening the reporting time for critical and urgent cases.
In an interesting study [74], DL was applied over electronic health records to determine
the top 20 factors related to lung cancer instead of prediction relying on self-reported
parameters, such as smoking, family, socioeconomic status, or BMI history of patients.
Time-related sequential information was also used as a parameter to evaluate lung cancer
risk. The use of a such predictive model could serve better to limit unnecessary radiation
exposure as well as to reduce the cost.
• Aging People and Arthritis
The progression of arthritis in the subjects, reported in Table A3 in Appendix A, indi-
cates interesting studies on how DL could be useful in solving arthritis-related issues in
aging subjects. The studies have shown that DL can be used effectively to prognosticate
joint pain or arthritis outcomes. Such diseases could otherwise trigger inflammation that
could lead to irreversible damage in aging people. The study in [75] demonstrated a com-
prehensive classification and regression analysis using a novel DL on rheumatoid arthritis
to determine concrete numerical predictions of disease activity instead of just classify-
ing high or low risk patients, henceforth making treating-to-(predicted)-target strategies
better. It was observed that female patients face a higher risk of clinical progression in
rheumatoid arthritis. Potentially, lifestyle, sleep or nutrition also contribute to disease
prediction. The DL model developed serves as a potential tool for clinical decision support
for patients suffering from rheumatoid arthritis. Leung et al. [76], predicted the risk of
osteoarthritis and the likelihood of the patient undergoing the total knee replacement,
using DL models. These models accurately predicted osteoarthritis progression in patients
requiring a total knee replacement within a nine-year time span than traditional grading
systems [76]. In this prognostic study [77], electronic health records were monitored for
medications, patient demographics, laboratories visited, and of disease activity measures
using DL models to prognosticate future patient outcomes for rheumatoid arthritis. This
study forecasted RA disease activity for future clinic visits to better guide specialized
treatment on an individualized basis. DL methods measured RA disease activity scores
across two healthcare systems and suggested that the disease activity, laboratory values,
and medications combined together are the strongest predictor of RA at every clinical
visit. DL models trained on the large and diverse patient populations proved to be robust
and provided useful insights for patient care. In an interesting study by Hirano et al. [78]
applied DL methods to assess radiographic finger joint destruction in RA by analysing
images of proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints. The
performance of the model was compared with the scores assigned by both the model and
clinicians (rheumatologists). Image processing with the DL model showed promising
results to assess radiographs in RA. Assessment by the model was observed to be <1 s per
image which proved faster than humans to make an assessment.
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• Alzheimer’s Disease (AD): A Common Disease in Aging People
Alzheimer’s disease (AD) is a progressive brain disorder that gradually destroys
brain memory, it is a common disease in aging people, which is caused by dementia.
DL approaches have shown promising results for automated diagnosis and the multi-
class classification of AD using resonance imaging and tomographic images (Table A4 in
Appendix A). Table A4 highlights the review of studies applying DL over AD subjects.
The accurate diagnosis of AD is important, especially at the disease’s early stages, so that
patients undergo preventive measures even before the occurrence of irreversible brain
damage. Deep Learning (DL) has become a common technique for the early diagnosis of
AD. Brain imaging techniques are used to visualize the structure and function of the human
brain. The most commonly used imaging technique of MRI helps in measuring brain
volumes indicating any kind of degeneration due to AD. For the functional connectivity
studies of the human brain, independent components analysis (ICA) has been widely used
for analysing neuroimaging data [79]. In the study by Qiao et al. [80], a DL-based method
was developed to distinguish AD from controls by fusing the functional connectivity. The
study detected the underlying biomarkers of AD by analysing functional MRI. Intrinsic
functional connectivity in AD patients was noted to be significantly reduced in subcortical
brain regions of the hippocampus, amygdala, insula and putam [80].
In a study by Qureshi et al. [81], AD patients with a clinical dementia rating (CDR)
were considered, and DL methods applied to functional magnetic resonance imaging data
of CDR indicated that the medial frontal, sensorimotor, executive control, dorsal attention,
and visual-related networks mainly correlated with dementia severity. The automatic
classification of AD severity groups has important contributions to clinical practice. The
study suggests that the DL-based classifier acts as a severity indicator, objectively and
accurately complementing the CDR scale in the evaluation of AD severity in the absence of
trained neurologists. This could further help in drug treatment according to the stage and
symptoms of AD.
Choi et al. [82], developed a brain image interpretation system, based on DL to ac-
curately predict cognitive decline in mild cognitive impairment (MCI) patients using
fluorodeoxyglucose and florbetapir positron emission tomography (PET) images. The
authors claimed their main contributions as to apply a DL model trained for differenti-
ating AD from controls, and to achieve the accurate prediction of cognitive decline with
minimally processed multimodal neuroimage data. Ding et al. [83] also developed a DL
method to improve the diagnosis accuracy of AD from fluorine 18 fluorodeoxyglucose
PET of the brain. The study [83] analysed whether or not the PET image belongs to class
AD, MCI, and non-AD/ MCI. The proposed method [83] could be integrated into clinical
workflow and serve as an important decision support tool to aid radiologists and clinicians
with early prediction of AD from PET imaging studies. On another hand, the study in [84],
highlighted that the invasive nature of PET-based processing and the low sensitivity of
identified biomarkers in PET-based studies may affect their application in real world rou-
tine clinical settings. Henceforth, the study in [84] aimed at building an AD diagnostic
classifier using deep learning/transfer learning, based on brain imaging-based MRI data
obtained from more than 217 different brain sites, constituting the largest sample. The
researchers [84] applied a DL-based model to build a sex classifier in transfer learning for
the objective diagnosis of AD. Nonetheless, the study [85] proposed a multi-modality AD
classifier taking into account both MRI and PET images of the brain areas as the inputs, and
provided predictions in classifying AD vs. controls, facilitating a fast-preclinical diagnosis.
It highlighted that the combination of two types of modality imaging data generates better
results [85].
• Prediction over Spectrum of Age-Related Issues
The studies [17,19,86–95], highlighted DL-based prediction of other age-related other
issues such as Type -2 diabetics, COVID-19 in older patients, coronary blockage in arteries,
age-related eye diseases, brain age with old age, age-related disease gene associations, and
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heart stroke. Interesting findings and summary of these studies [17,19,86–95] is provided
in Tables A5 and A6 in Appendix A.
Shown in Tables A1–A6 are the AUC measuring the area under the ROC (receiver
operating characteristic), a trade-off curve between the true-positive-rate and the false-
positive-rate [96]); accuracy, measuring the fraction of predictions that the proposed model
got right) [96] and mean absolute error, which is a measure of errors between paired obser-
vations expressing the same phenomenon [97], all of which are noted as the performance
measure of the reviewed publications to indicate their effectiveness. Better AUC and
accuracy indicate better predictions, whereas lower MAE indicates better predictions. In
general, overall high performance was achieved (>84% AUC) by adopting DL models in
predicting aging-related diseases (Figure 9). Remarkable performance (high AUC of 98%)
was achieved in studies involving DL [83] to predict AD in aging people.
Figure 9. Predictive performance of DL methods applied to aging-related diseases.
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The studies (Tables A1–A6 in Appendix A) have demonstrated that the use of DL
techniques in analysing medical images, such as frontal and lateral images of the heart,
MRI, chest scan images, neuroimages, and fundus images, provide evidence in terms
of predicting different age-related issues, which could further facilitate their diagnosis.
However, the imaging data typically lie in a high-dimensional space which may lead to the
risk of overfitting by the DL models. To address this, feature engineering tools are needed,
especially in the case of small sample size and high dimensionality. As reported in some
selected studies [16,80,90,92,98], DL models can benefit from their feature engineering
capability and have been shown to outperform traditional ML models in the prediction of
multiple age-related conditions. CNN has also been used to extract features from input
ECG signals to predict cardiovascular diseases [71]. ECG data are primarily streaming data
that are continuous and are of high density. The studies indicated that the DL model can
capture the spectral changes in ECG well to distinguish different states (diseased or not).
For EHRs, it was observed that longitudinal DL models performed better [77].
The use of genomic data in DL in studying age-related conditions shows promising
direction, but domain knowledge is needed to guide the DL model extracting patterns [48].
Some interesting studies have shown the usage of sensor data for guiding and predicting
age-related issues [87,88,95]. However, data gathered from sensors may have a certain
degree of errors, noise, or redundant information due to battery or communication loss
in sensor readings. Hence, such studies prefer to use pre-processing steps such as denois-
ing, transformation, or segmentation for dealing with noise before the application of DL
methods.
4. Discussion
DL has been playing an important role in providing healthcare professionals with
insights, which aids in the detection of health issues early on aging, leading to better patient
care. DL has been used in various spheres involving medical image analysis of critical
aging diseases, genomics to link genes with diseases, EHR data for personalized care,
analysing medical history and providing drugs based on it, cell scope recording medical
data on devices, and decreasing frequent visits to consult clinicians. Different types of
un-structured and complex data emerging in today’s medical world around aging people
are converted into useful formats using DL models. DL models further aid clinicians in
the medical classification of diseases, medical resilience, segmentation, cellular senescence,
and various other tasks. DL is recommended in dealing with the health of elderly people
due to its following benefits:
• DL learns the important patterns or relationships in large amounts of healthcare
data and allows clinicians to perform model-based analysis integrated with their
observations; leading to smart care achievable from such big data.
• Remarkably, DL has achieved human-level performance in disease classification,
learning over patterns/objects contained in medical images.
• When DL is applied over the training data, it becomes more precise with multi-stream
architecture and subsequently provides more accurate insights into care processes and
diagnostics of aging diseases.
• DL helps in the detection of clinically relevant features by learning patterns in medical
imaging data beyond as perceived by a human observer/clinician.
• DL approaches are now leading to lower costs and improved and faster outcomes in
monitoring the health of aging people.
• DL provides end-to-end learning models for heterogenous, uncertain and complex
medical data.
• DL provides clinicians with the support they need to understand medical environments.
The purpose of this review is to investigate state-of-the-art applications of DL in study-
ing and predicting diseases that may relate to aging people. Out of 1804 articles on Google
Scholar, PubMed and IEEE, based on our keyword-search terms and subsequently sorting
by relevance, 34 studies met our inclusion criteria, and these were reviewed. Interestingly,
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these involved varied data types, such as imaging data [78,81,82,89–91,98], EHR data [77],
ECG data [71], fundus images [67,69,92] and sensor data [87,88,95]. From these studies,
we observed that there is a surge in the application of DL methods for studying such
diseases. Multiple studies have developed DL methods for disease prediction using clinical
and/or non-clinical data and attained promising results. Compared with the conventional
classification ML models, most of the reviewed studies involving DL models reported
higher prediction performance [72,75,86,88]. These findings pave the path to DL models,
assisting clinical experts in better diagnosing health conditions in elderly people.
By making accurate automated diagnostics of a variety of aging-related diseases, DL
methods help in preventing reporting delays for critical conditions, reducing the burden
on clinicians, and decreasing errors in diagnosis by auditing diagnostics and care. DL
models can make effective interpretations by flagging important areas in medical-related
images of aging people, such as in early detection of AD, diabetic retinopathy, and lung
nodules. DL-based modelling also applies its neural network architecture to electronic
patients’ records, medical reports, time series of electrograms, insurance records, etc. to
provide the best outcomes. Thus, DL provides patients with better treatment.
DL is also used to understand a genome and help patients to identify genes causing
diseases that might affect them [48]. Nowadays, patients can monitor their health with
smart sensor-based devices in real time, thus minimizing frequent visits to the doctor.
DL over data collected from smart devices could aid patients in providing better health
care [87].
In this review, we collected studies that analyse different types of clinical information,
highlighting its ability to address disease predictions in aging people. With the advent
of omics sciences, it is imperative to take an integrative approach combining multi-omics
data along with clinical information, deriving useful cellular functions to understand
age-related diseases more systematically and holistically. DL models seem promising in
the area of integrating domain knowledge to identify meaningful patterns from medical
profiles [15,71]. However, experts fear that, due to the design architecture, DL models
appear to be “black boxes”, without showing details of inner working to reach from raw
images for disease predictions [99,100]. Nevertheless, efforts have been made in improving
the interpretability of DL in healthcare [101]. Three essential components in DL models are:
the learning goal, objective function (or loss function) to be maximized or minimized; and a
set of learning rules for networking architecture frameworks as discussed in Section 1.2. In
this framework, researchers are not concerned with how computations are performed, but
rather enable the learning of computations with the three above-mentioned components
(goal, objective-function and rules) [101]. However, DL models developed for neuroscience
and healthcare could benefit from better optimization of objective functions with the
constraints handling diverse biological and medical data.
It is expected that DL black boxes would yield better impact when combined with
predictive modelling approaches where existing medical domain expertise is formally
integrated, generating better and novel treatments, as highlighted by Geerts et al. [102].
Additionally, the study in [82], created an interpretation system, based on a deep CNN, to
predict future cognitive decline in Alzheimer’s disease. Delivering clinical impact is one of
the key challenges for applying DL in the field of healthcare predicting human diseases. As
highlighted in this review, applicable DL systems [82,88,94] have been developed; however,
it has been argued by the researchers that putting DL technologies from research into
clinical practice requires robust system design and clinical evaluation [100]. The format of
presentation is an important criterion, while considering the DL-based disease prediction
model in clinical practice [103]. A prototype model should undergo a detailed validation
process before it is deemed suitable for clinical use [103].
In the disease prediction estimation of the probability that a patient suffers from a
disease or not, clinicians would be interested in recognizing patterns in data associated with
the disease for guiding better interventions. Rapid progress in imaging and sequencing
techniques has made it challenging to integrate large-scale, high dimensional multimodal
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medical data. Therefore, the research community is progressing towards the use of DL
approaches for integrative analysis.
Nonetheless, one of the challenges in the field of applying DL to the medical domain
is the availability of large-scale data pertaining to patients. This could lead to the problem
of the “curse of dimensionality” which demands the careful optimization of the model
parameters to avoid overfitting. Many modelling parameters tend to adapt a DL model too
much, leading to overfitting. However, this could be reduced through various regulariza-
tion methods in DL [104]. DL algorithms usually assume sufficient and balanced training
data, which may also not be possible in some real case healthcare scenarios.
Most studies pertaining to the application of DL in disease detection uses features
automatically extracted by DL models, such as CNN. However, as one of the future
pointers, an ensemble of several features may be explored to provide better detection
results. An ensemble of different DL methods could also be considered for potentially
better predictions, because ensembles perform many times better than a base classifier.
One potential way to reduce the dimensionality of the data is by feature engineering before
feeding information to the DL models or the use of transfer learning [85,91]. The transfer
scheme was demonstrated to be able to improve predictive performance.
Additionally, due to ethical issues involved in human studies, some researchers used
personal datasets. However, more public repositories could be built after deidentification as
it would provide the research community with more data to test the efficacy of DL models.
Another limitation that has been observed is that the DL models become computationally
expensive to train images of larger size, and sometimes it is also time consuming to train a
DL model over such big data.
The studies (Table A6) involving data collected from sensors for aiding health care and
lifestyle monitoring in old age, may have a certain degree of erroneous, or noisy information
because of the involvement of sensors, which poses a challenge to form computational
modelling. Henceforth, pre-processing steps (e.g., data denoising, data and transformation)
are necessary before inputting the DL models.
Due to characteristics of data involved in the medical care of heterogeneity, longitu-
dinal, patient-centred records (both structured and unstructured), and streaming of data
(e.g., electrograms), analyses are computationally more expensive, which poses a challenge
for the DL model architecture selection. An efficient model should aim for fewer training
parameters. Due to domain heterogeneity, researchers have the chance to study age-related
problems from different aspects, such as genomic, clinical, medical imaging and sensor
signals. Integrative modelling of such multimodal data could provide better insights into
elderly diseases.
The “No Free Lunch Theorem” indicates that no learning algorithm can perform well
on all possible issues/problems [105]. Hence, no one DL model could be chosen to perform
better in diseased use cases.
Future pointers indicate enhancing DL techniques with the therapeutic intervention
of diseases. To discover complex disease patterns with different facets from medical
data, computational models need to go deep and various DL architectures (with careful
modelling of parameters), hold great promise in this endeavour. Healthy aging is becoming
important and DL architectures hold the promise for addressing the challenges of old age.
5. Conclusions
The current scoping review focused on the use of DL techniques to study the diagnosis
and prognosis of aging diseases in the growing population. DL methods and their appli-
cations in the medical domain, catering to elderly people, continue to evolve, producing
better performance. As time progresses to the year 2021, more research work on disease
detection in aging people using DL has been published. This paper is thus produced to
offer a survey of the role of DL in aging-related issues, specifically focusing on diseases
such as AMD, arthritis, cardiovascular and respiratory diseases, Alzheimer’s, and other
neurodegenerative disorders while associating human genes with diseases, analysing data
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collected from wearable sensors for better health and lifestyle; all of the studies were
published recently (2017–2021). We discussed the dynamics of predictions over health
issues and diseases in the aging population, inspired by the way DL provides revolutionary
insights. DL algorithms have achieved excellent performance in various predictive tasks
associated with aging diseases. Henceforth, DL could also aid in the healthy aging process.
The results reviewed in this work depict the promise of DL in improving the diagnosis and
treatment of aging health issues.
Compared with existing related literature reviews, this article provides a scoping
survey of the multiple diseases in the aging population and their diagnosis with DL with
the challenges also faced in this field. Moreover, methods need to be further extended to
integrate a variety of data formats of the medical domain in a DL network. To achieve
a similar goal, medical imaging data, contextual data from EHRs and multiomics data
can be combined leveraging DL for integration of multimodality data. Multiomics data
are nowadays also widely used for disease detection and treatments. Methods adopting
an integrative approach to analyse multiomics with other available medical data have
the ability to address applications, such as disease prediction, biomarker identification,
and deriving useful insights from medical data. DL techniques, such as autoencoder
models, have the potential to integrate multiomics data with medical data for extracting
representative features. Integrative analysis could potentially provide an effective way
to borrow advantages from multi-level, heterogeneous medical and omics data. From
the analyses of the distribution of works in the current review, the usage of CNN and its
variants is used for predicting diseases involving image classification. The expansion of 2D
CNN into 3D CNN is progressing, especially in the study of neurogenerative disorders in
the aging population, which deals with multimodal images [17,71,81,89]. Research using
DL is still evolving to achieve better performance and visibility.
In conclusion, our review suggests that the development of novel methods making use
of DL is acceptable as an objective, complementing the prediction of diseases in the aging
population. To facilitate clinicians, researchers could objectively and accurately classify
the diseased states using DL. The review presented valuable insights and informed the
research in DL, related to the healthcare of elderly people. DL methods were used for
pre-processing of medical data and in the analysis, visualization and optimization of deep
neural networks in studying aging-related issues.
Research using DL is still evolving to achieve better performance. As medical data
grow rapidly, research on the diagnostic classification of aging diseases is shifting towards
DL models or their ensembles, integrating completely different formats of data in a DL
framework. In the future, new DL modelling architectures could be designed and explored
further to provide better clinical presentations for routine care of aging people.
Author Contributions: Conceptualization, J.T.W., H.Z. and H.W.; writing—original draft preparation,
J.T.W.; writing—review and editing, H.W. and H.Z.; supervision, H.Z.; project administration, H.Z.
All authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Acknowledgments: We are grateful to the clinical and computational researchers who reported their
results, facilitating further the reporting, analyses and discussion in this scoping review.
Conflicts of Interest: The authors declare no conflict of interest.
Cells 2021, 10, 2924 21 of 34
Appendix A
Table A1. Application of DL in AMD.
Authors Application Material and Methods Important Findings Performance Reference
Qi Yan et al.
In this study, both genotypes and
fundus images are used to predict
age-related macular degeneration
(AMD) with a deep CNN.
The study used 31,262 fundus images and 52
AMD-associated genetic variants from 1,351 subjects of
Age-Related Eye Disease Study over a period of 12
years. The subjects were between 55 and 80 years old at
the baseline. The Inception-v3 CNN architecture was
used to extract image features. Pre-trained weights
were used to train the network using the ImageNet
database. Three-level severity labels—no AMD, early
or intermediate AMD; and late AMD were used in the
study.
The study first time jointly used genotypes
and fundus images in a prediction mode,
enhancing the predictive performance of
detecting severity of AMD.






The study focuses on disease
classification and to detect
treatment-requiring retinal
vascular diseases including




(mCNV), branch and central retinal
vein occlusion (BRVO/CRVO) in
elderly people using multimodal
imaging.
The study was conducted over the enrolled participants
with multimodal ophthalmic imaging data from 3
hospitals in Taiwan from 2013 to 2019. EfficientNetB4
[106] was used as the convolutional neural network
(CNN) as the multimodal classification model.
First study to use multimodal DL–based
architecture for detecting multiple retinal
vascular diseases using multiple image
modalities, including retinal fundus
photography, OCT, and FA/ICGA, for
predicting neovascular retinal diseases.
Developed model does not depend on a
fixed image distribution for different
modalities. The model highlighted areas
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Table A1. Cont.
Authors Application Material and Methods Important Findings Performance Reference
Peng et al.
The study deals with classification
of patient-based age-related
macular degeneration (AMD)
severity from colour fundus
photographs.
DeepSeeNet was developed consisting of three
sub-networks by detecting AMD risk factors including
pigmentary abnormalities for human eyes and then
calculating a patient-based AMD severity score
utilizing the age-Related Eye Disease Study (AREDS)
simplified severity-scale.
DL model was trained on 58,402 images and tested on
900 images obtained from the 4549 participants from
AREDS.
DeepSeeNet consists of three constituent parts that
contribute to its output: (a) a sub-network, Drusen-Net
(D-Net), which detects drusen in three size categories
(small/none, medium, and large); (b) a sub-network,
Pigment-Net (P-Net), which detects the presence or
absence of pigmentary abnormalities
(hypopigmentation or hyperpigmentation); and (c) a
sub-network, Late AMD-Net (LA-Net), which detects
the presence or absence of late AMD (neovascular
AMD or central GA)
DeepSeeNet is publicly available online:
https://github.com/ncbi-nlp/DeepSeeNet accessed on
17 October 2021).
AMD possibility increases exponentially with age: as
estimated by meta-analysis at 6% at 80 years and 20% at
90 years.
The study proposed a model for better
clinical decision support, mimicking the
human grading process by first detecting
individual risk factors of drusen and
pigmentary abnormalities in each eye and
then combining values from both eyes to
develop an AMD score for the patient. This
study shows that DeepSeeNet performed
patient-based AMD severity classification
with a higher level of accuracy than as








The study highlights how DL
algorithms could better
characterize age-related macular
degeneration from fundus images,
assessing the severity of
Age-Related Eye Disease.
The study utilized the AREDS data set from National
Institutes of Health, including samples from 13
November 1992 to 30 November 2005, dealing with
67,401 colour fundus images from the 4613 study
participants. To perform classification, deep
convolutional neural networks (DCNNs) of ResNet-50
network was used. It consisted of many computational
layers that performed convolutions and the related
nonlinear activation operations.
DL outlines fundus and OCT image analysis,
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Authors Application Material and Methods Important Findings Performance Reference
Banerjee
et al.
The study proposed hybrid
sequential prediction model called
“Deep Sequence”, integrating
imaging demographic, and visual
features with DL to predict the risk
of exudation within AMD suffering
eyes where eyes may convert from
dry to wet when patients who
progress to AMD. This may cause
loss of vision too.
The study was conducted over the clinical trial dataset
that includes 671 AMD fellow eyes with 13,954
observations of patients up to 85 years of age. It
analysed longitudinal OCT imaging features and
demographic information in an RNN model to predict
the exudative event in eyes with AMD within 3–21
months span.
The importance of this study lies in
integrating advanced imaging with
sequential deep learning, RNN model, for













Table A2. Application of DL in cardiovascular and respiratory diseases.




The study analyses and explore the
application value of DL for the
prediction of possible
complications of coronary heart
disease, and its effect on
improvement of nursing and care.
DL was applied to data of 182 patients (age from 48 to
80 years old, average age: (65.27 ± 7.34) years old),
collected from health records, including their previous
medical history, clinical diagnosis, examination results,
abnormal indicators, living habits and other
information.
High-risk patients with coronary heart
disease indicate relation with old age,
medical history,
characteristics such as lack of cognition and
unhealthy lifestyle. DL Application could
effectively predict the risk of related








Heart disease is one of the primary
causes of death after age 65 and,
with the world population aging.
This study gain insights from DL
models aiding in predicting heart
age.
The study involved training of magnetic resonance
videos MRI videos with 3D CNN, images with 2D
CNN, time series ECG with 1D CNN over 45,000 heart
MRI and electrocardiograms [ECG] from the UK
Biobank within the range 45–81 years.
The study reported biomarkers, clinical
phenotypes, diseases, environmental and
socioeconomic biomarkers associated with
accelerated heart aging. The study also
highlighted the aorta, the mitral valve, and
the interventricular septum as key









2.89 ± 0.02 years
vs. 6.09 ± 0.0.02
years).
[71]
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Table A2. Cont.




The study aims to predict Chronic
obstructive pulmonary disease
(COPD) using DL methods.
The study uses 6749 two-view chest radiograph exams
(2012–2017) involving mean age as near to 60 years, also
discussing COPD case of 62-year-old female. The
frontal and lateral images are fed as inputs to two
parallel convolutional neural networks (CNN) with
pulmonary function tests (PFT) annotation.
A CNN Model trained on chest radiographs
for quantitative prediction of COPD
performs better than state-of-the-art
algorithms of Natural Language Processing
(NLP) in the field, attaining good accuracy.













calcification and cardiomegaly) to
evaluate its impact in predictive
diagnostic and judging the
timeliness of reporting.
The proposed approach used a ResNet34-based deep
CNN over samples with mean ± SD age 57.6 ± 17.9
years on the chest radiographs.
The proposed model advanced the reporting
time for critical and urgent cases, aiding


























To predict a patient’s risk of
developing lung cancer, using DL
approaches
The analysis included 11,617 patients with lung cancer
and 1,423,154 control patients with mean age 66 years.
A total of 9261 cases of lung cancers were identified in
subjects with age >= 55. CNNs have been applied to
radiographic images of chest and to facilitate detection
and low-dose computed tomography classification of
pulmonary nodules in lungs. Xception architecture
which includes a 126-layer CNN-based neural network
with a moderate number of parameters, was used for
feature extraction.
The study involved time-related sequential
information from the medical histories to
evaluate lung cancer risk in patients rather
than relying on does not rely on smoking
status, socioeconomic status, or BMI.
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Table A3. Application of DL in arthritis.
Authors Application Material and Methods Important Findings Performance Reference
Kalweit
et al.
The study investigated use of DL
for the prediction of rheumatoid
arthritis.
An adaptive recurrent neural network (AdaptiveNet), a
dynamic and recurrent deep neural network
architecture, designed for chronological clinical data
was trained on the data collected from over 9500
patients from the Swiss Quality Management (SCQM)
database.
Disease prediction was improved over
patients having longer disease duration, age
> 50 or having antibody positivity. Also,
when compared to the ML models of linear
regression, random forest and support







A multitask DL model was applied
over knee radiographs to
accurately classify patients with
high-risk osteoarthritis in both
patients who underwent knee
replacement (TKR) and the control
patients who did not.
The proposed model used a transfer learning approach
based on the ResNet34 architecture to evaluate 728
participants (with mean age, 64 years ± 8).
Accurately predicted osteoarthritis in
patients who would be requiring knee
replacement in 9 years.







Longitudinal DL models were
developed for predicting disease
activity of rheumatoid arthritis
A fully dense DL architecture was applied over the data
of 820 patients that were extracted from the EHRs of 2
different hospitals: a university hospital (UH).
rheumatology clinic (University of California, San
Francisco) and a rheumatology clinic from a safety-net
hospital (SNH) (Zuckerberg San Francisco General
Hospital) (mean age, 57–60 ± 15 years).
Models developed for predicting
rheumatoid arthritis disease from EHR data,
is informative with quantifiable outcomes in
the outpatient setting.
AUC of 0.91 (95%
CI, 0.86–0.96) [77]
Hirano et al.
The study predicted radiographic
finger joint destruction in
rheumatoid arthritis (RA).
The network of the CNN consists of two convolution
layers, two pooling layers and three fully connected
layers was applied over the data of 216 radiographs of
108 patients with RA, for joint evaluation. Finger joints,
such as PIP, IP and MCP joints, were detected by the
model and scoring scheme was used by CNN to judge
the differences between joints. Radiographs in the
testing dataset were used to evaluate the trained CNN
model by comparing scores assigned by the model and
by clinicians.
Interquartile range of (53.5, 72.6) years old was taken
for this study.
Processing radiographic images and
determine joint destruction with the trained
convolutional neural network model is
promising. The authors claimed to apply
CNN for the first time to detect joint
destruction in RA, (particularly joint space










The study aimed at developing an
automated classification model for
Knee osteoarthritis (KOA) based
on features extracted from DL
model.
Radiographic image features extracted from a DL
network, namely, Inception-ResNet-v2, were further
exploited using a support vector machine for KOA
multi-classification.
The proposed model outperformed a
common DL approach that is based on using
only radiographic images as the input data.
Highest AUC of
0.93 was achieved. [98]
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Table A4. Application of DL in AD.
Authors Application Material and Methods Important Findings Performance Reference
Qiao et al.
The study proposes DL
classification framework with
multivariate data-driven based
feature extraction for automatic
diagnosis of AD.
34 participants with mean age 68.64 ± 9.85 years, were
taken as sample from memory outpatient clinic at the
Huashan Hospital of Fudan University. A total of 34
participants with mean age 65.55 ± 8.98 years, were invited
by public advertisement to take part in the study. The
proposed method was based on a three-level hierarchical
partner matching independent component analysis
(3LHPM-ICA) and Granger causality (GC) to determine
effective connectivity features playing role in AD diagnosis.
Identified brain features that can serve as






The study performed automatic
assessment of dementia severity
using a DL framework applied to
resting-state functional magnetic
resonance imaging (rs-fMRI) data.
The demographics included the participants with mean age
of 73. The 3D-CNN-based DL classification framework is
used in this study to assess dementia.
The research supported automatic
classification of AD into two groups of
disease severity (very mild and mild vs.
moderate and severe) enabling









The study aims to develop an
automatic image interpretation
system based on a deep
convolutional neural network
(CNN) to predict future cognitive
decline in mild cognitive




Deep CNN was trained using 3-dimensional PET volumes
of AD.
The data used in this study included subjects recruited in
Alzheimer’s Disease Neuroimaging Initiative-II (ADNI-2)
with available baseline data on FDG and AV-45 PET
(http://adni.loni.usc.edu, accessed on 17 October 2021)
with a mean age of 73 years.









A DL algorithm is used for an early
prediction tool for Alzheimer’s
disease providing therapeutic
intervention by using biochemical
and imaging tests.
PET imaging studies from 1002 patients, from Alzheimer’s
Disease Neuroimaging Initiative (ADNI)-1, ADNI2, and
ADNI-GO (Grand Opportunities) studies was considered.
The average age of the patients was 76 years (range, 55–93
years) for men and 75 years (range, 55–96 years) for women.
Convolutional neural network architecture, Inception v3,
was used in this study stacking over 11 modules where
each module consists of pooling layers and convolutional
filters with rectified linear units as activation function over
the two-dimensional images of 16 horizontal sections of the
brain.
A DL algorithm developed for
successful early prediction of
Alzheimer’s disease by using fluorine 18
fluorodeoxyglucose PET of the brain.
AUC of 98% for
predicting AD. [83]
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Table A4. Cont.
Authors Application Material and Methods Important Findings Performance Reference
Lu et al.
The study is aimed at identifying
the stage of Alzheimer’s Disease
(AD) patients through the use of
mobility data and DL models.
The study applied a state-of-the-art architecture deep
convolutional neural network, Inception-ResNet-V2, to
pre-train brain images involving elderly people of age > 65.
Modelling to classify AD, showed
outstanding characteristics as a
progression biomarker. Interestingly, the
study involved weighted brain




found to be >90%.
[84]
Huang et al.
The research proposes a practical
brain imaging-based AD
diagnostic classifier using
DL/transfer learning on MRI
dataset of unprecedented size and
diversity.
The data were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database. The study chose
2861 T1-MR images, including AD subjects with a mean
age of 76.13 ± 7.50. The study proposed a multi-modality
CNN-based classifier for AD diagnosis and prognosis.
The work distinguishes between AD or
potential AD patients from cognitively
unimpaired (labelled as CN) subjects
accurately and automatically using
medical images to facilitate a
fast-preclinical diagnosis.





Table A5. Some more applications of DL dealing with aging-related issues.
Authors Application Material and Methods Important Findings Performance Reference
Titano et al.
The study applied a novel DL




scans from patients referred to a
major eye, London, United
Kingdom.
3D U-Net architecture was used to determine referral
recommendation to clinicians for disease prediction
involving OCT scans of majority people of age > 50, on
a range of sight-threatening retinal diseases. Data was
collected about raw retinal OCT scans around the
macula). Deep segmentation network was trained with
manually segmented OCT scans to determine tissue
map images. Deep classification network, was then
trained over the tissue maps with diagnoses of disease
with predicted diagnosis probabilities providing
recommendations to the clinicians.
The study presented a novel framework that
analyses clinical 3D OCT scans and makes
referral suggestions to a standard
comparable to clinical experts.
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Authors Application Material and Methods Important Findings Performance Reference
Betancur
et al.
The study applied DL for
prediction of obstructive disease
from myocardial perfusion
imaging (MPI). Obstructive disease
was defined as ≥70% narrowing of
coronary arteries.
The study comprised of 1638 patients from 2008 to 2015,
at 9 national and international (Canada, Switzerland,
Israel) sites with mean age of 65.2 ± 11.0 in obstructive
disease.
The feature maps comprised of 3 fully connected layers
transformed the image features into the final scores.
The potential of DL for prediction of
obstructive diseases from MPI, as compared
with the standard quantitative analysis of











The study applied DL model based
on quantitative computed
tomography (CT) images to predict
the severity of current global
pandemic COVID-19.
196 patients with confirmed COVID-19 those were
enrolled from 20 January to 10 February 2020, Shanghai
Public Health Clinical Centre, Fudan University, China,
were considered for analysis. CT images help in
studying prognostic and diagnostic characteristics of
COVID-19, the quantification of these with DL is useful
to predict he severity of disease. The median age of the
severe group considered in this study was 65 years.
Methodology utilized the V-shaped neural network
(V-Net) which is a convolutional neural network (CNN)
and combined it with transfer learning to segment the
infected regions on images.
DL over CT model containing radiological
features serve as an efficient tool for
prediction of COVID-19 severity. CT
suggests disease progression and it was
found that with other age-related diseases,
CT has prognostic value for predicting
mortality.








DL is applied to extract novel
features such as refractive error
from retinal fundus imaging in a
novel way.
Retinal fundus images used in this study were obtained
from the UK Biobank and the Age-Related Eye Disease
Study (AREDS) clinical trials.
Refractive error is one of the most common causes of
visual impairment in age related issues worldwide. A
DL model residual network (ResNet) consisting of three
residual blocks, an attention layer to learn the most
predictive eye features, and two fully connected layers
was trained to predict the refractive error from fundus
images. Poor quality images were excluded to be fed
into DL model.
Successfully found features that predict
refractive error in retinal fundus in patients.
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Authors Application Material and Methods Important Findings Performance Reference
Nguyen
et al.
The study applied DL model
combined with generalized linear
model improve the prediction of
the onset of type 2 diabetes
mellitus (T2DM)
The dataset consists of identified electronic health
records for 9948 patients, of which 1904 have been
diagnosed with T2DM of age-range up to 84 years.
Using DL over EHRs aids better in
predicting the onset of diabetes and useful
in improving the quality and efficiency of
medical care





Aging has a significant structural
impact on the brain that correlates
with decreased mental and
physical fitness. The current study
focusses on determining brain age
to predict neurodegenerative
diseases from a T1-weighted MRI.
The proposed method uses a 3D CNN trained on MRIs
to predict brain age. CNN is validated on 104 images
from the IXI dataset left out during training (validation
set) and tested on 12,395 images from the UK Biobank
dataset.
CNN derives on five residual blocks, each followed by
a max pooling layer of stride 2× 2× 2 and kernel size
3× 3 × 3, and one fully connected block.
T1-weighted MRIs are useful to predict
brain age associating them with neuro
degenerative diseases and achieved
promising results.





The study was aimed at predicting
whether human genes are
associated with several age-related
diseases at the same time using
Deep Neural Network (DNN)
methods.
DNN with three fully connected layers followed by an
output layer to predict whether each s gene is
associated with age-related diseases (27 classes of
diseases). Human protein coding genes were obtained
from NCBI BioMart v. 87, and age-related disease gene
associations were the subset of the Genetic Association
Database.
Popular genes were identified that are
strongly linked to aging-related diseases.
Use of DNN improved the predictive
performance.








The study aims towards early
prediction of dementia using CNN
(convolutional neural networks), a
DL method is over neuroimaging
data
150 subjects aging from 60 to 96 years old. The study
fed images in a type of image retrieval system, using
the CNN method and the proposed technique of using
CapNet. The proposed model uses the modified
capsule network technique for classifying the dementia
groups into demented and non-demented category.
Age is the most dependent feature for
Dementia. The proposed model can handle
hierarchical modelling problems and is
computationally more efficient with better








The study proposes use of deep
neural networks to detect stroke
patient mortality using medical
service and health behaviour data
Subjects collected from 2013 to 2016 by the Korea
Centres for Disease Control and Prevention with mean
age of 66 years. The study proposed DNN/scaled
principal component analysis (PCA) to automatically
generate features from the data and identify risk factors
for stroke. Feed-forward neural networks were trained
using a standard backpropagation.
Early detection of patients at high risk of
stroke who would need additional attention
before disease exacerbation.
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Table A6. Application of DL in predicting other aging-related issues using sensor-based data.
Authors Application Material and Methods Important Findings Performance Reference
Papagiannaki
et al.
Use of DL in physiological
monitoring of older people using
wearable sensors for improving
their health status and quality of
life.
The study involved convolutional neural network
architectures (CNNs) in recognizing movement
patterns of older people. Three CNN layers were used
and of which each convolutional layer is followed by a
normalization layer and a rectified linear unit (ReLU)
activation unit. The recordings were obtained from
older people aged 70–92 who participated in the
FrailSafe project available online:
https://frailsafe-project.eu/ (accessed on 17 October
2021).
The study proposed DL-driven activity
recognition scheme for older people
involving feature extraction with












The study proposes detection and
assessment of Parkinson’s disease
(PD) using wearable sensors,
highlighting the suitability of DL
over the collected data.
Analyses was conducted over the sample of 1815
participants over the age of 45 years.
The study indicated similarity between
classification of manually extracted feature
set, and the features learnt by a CNN in
diagonisis of PD. The study also indicated
the suitability of DL for assessing PD when











The purpose of this study is to
identify daily activities that
consider a key to falling cases for
older adults at care homes.
A deep activity CNNet was used to determine features
recorded from daily activities sensors data and to
associate them with highest falling risk activities in
testing data. People aged 66–86 years, participated in
the experiments.
DL techniques aid in effectively assessing
fall risk based on wearable sensors looking










To distinguish between stressed
and non-stressed state in older
adults using wearable technologies
and application of DL to
improving the quality of life in
aging. Chronic stress is one of the
risk factors in contributing to the
development of Alzheimer’s
Disease (AD) also in older people.
A finger-tip sensor was used during the Trier Social
Stress Test, to reliably induce stress in humans (within
social setting) to record signals. DL model of recurrent
neural network using Long Short-Term Memory
(LSTM) was applied over the collected data to classify
older people into stressed or non-stressed state. Data of
19 healthy older adults (11 female and 8 male) with
mean age 73.15 ± 5.79 were used for this study.
DL-based LSTM classifier attained better
performance than traditional ML models in
distinguishing between stressed and
non-stressed state. An efficient system for
unobtrusive wearable device system for
physiological stress detection in older adults
was devised aiding in prevention of







The study is aimed at identifying
the stage of Alzheimer’s Disease
(AD) patients through the use of
mobility data and DL models.
The study applied a state-of-the-art architecture deep
convolutional neural network, Inception-ResNet-V2, to
pre-train brain images involving elderly people of age >
65.
Modelling to classify AD, showed
outstanding characteristics as a progression
biomarker. Interestingly, the study involved
weighted brain structural image and
information on participant sex.
Accuracy of AD
classification
found to be >90%.
[84]
Huang et al.
The research proposes a practical
brain imaging-based AD
diagnostic classifier using
DL/transfer learning on MRI
dataset of unprecedented size and
diversity.
The data were obtained from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI) database. The study
chose 2861 T1-MR images, including AD subjects with a
mean age of 76.13 ± 7.50. The study proposed a
multi-modality CNN-based classifier for AD diagnosis
and prognosis.
The work distinguishes between AD or
potential AD patients from cognitively
unimpaired (labelled as CN) subjects
accurately and automatically using medical
images to facilitate a fast-preclinical
diagnosis.
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